The WHO List of Essential Medicines presents a list of minimum medicine needs for a basic health‐care system, listing the most efficacious, safe and cost-effective medicines for priority conditions. Priority conditions are selected on the basis of current and estimated future public health relevance, and potential for safe and cost‐effective treatment.
In 2017 the ILDS and Global Action Fund for Fungal Infection (GAFFI) were successful in our application to add Itraconazole and Voriconazole to the Essential Medicines List.
This will help treat many of the 300 million people of all ages who suffer from serious fungal infections every year.
In 2019 we were successful in our application to add Ivermectin for the indication of scabies to the Essential Medicines List.
Our work in 2019-2020 will focus on reviewing the Essential Medicines List to identify other medicines for skin disease, not currently under dermatological inclusions, in preparation for submission at the next List review in 2021.